Showing results (31-40 of 406) with videos related to
Sort By:
Pageof 41
Arthritis Research & Therapy|July 1, 2004
Perspectives and limitations of gene expression profiling in rheumatology: new molecular strategiesThomas Häupl, Veit Krenn, Bruno Stuhlmüller, et al.Autoimmunity Reviews|August 22, 2006
Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapyLorena Martinez-Gamboa, Hans-Peter Brezinschek, Gerd R Burmester, et al.The Journal of Rheumatology|July 18, 2008
Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center studyAnnegret Kawald, Gerd R Burmester, Dörte Huscher, et al.Nature Reviews. Rheumatology|June 16, 2017
Managing rheumatic and musculoskeletal diseases - past, present and futureGerd R Burmester, Johannes W J Bijlsma, Maurizio Cutolo, et al.The Lancet. Rheumatology|January 22, 2024
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trialMichaela Koehm, Tanja Rossmanith, Ann C Foldenauer, et al.RMD Open|June 5, 2021
Fluorescence optical imaging: ready for prime time?Sarah Ohrndorf, Anne-Marie Glimm, Mads Ammitzbøll-Danielsen, et al.Rheumatology International|November 12, 2018
Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in GermanyKlaus Krüger, Gerd R Burmester, Siegfried Wassenberg, et al.BMJ Open|June 16, 2018
Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in GermanyKlaus Krüger, Gerd R Burmester, Siegfried Wassenberg, et al.RMD Open|September 21, 2023
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: limitations and opportunitiesMichaela Koehm, Frank BehrensJournal of Neuroimmunology|December 20, 2005
CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progressionDagmar Gärtner, Holger Hoff, Ulrike Gimsa, et al.Pageof 41